FOXM1 and renal cell carcinoma: In the present study, we revealed that LOC653786 promoted growth and cell cycle progression of RCC cells via elevating FOXM1 and its downstream targets cyclin B1 and cyclin D1, indicating that the pathway ‘LOC653786/FOXM1’ is a novel mechanism by which LOC653786 accelerates RCC cell growth and cell cycle progression.